Excessive IL-22 in the cancer microenvironment leads to tumor growth with the activation of the STAT3 pathway [203], and the epigenetic activation of genes with a STAT3-dependent pathway maintains the CRC stem cells [59]. This evidence concerns the gene STAT3 and colorectal carcinoma.